Speedboat UltraSlim™ for POEM in adults with achalasia and other esophageal motility disorders.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center registry enrolling adults who undergo clinically indicated per-oral endoscopic myotomy (POEM) using the Speedboat UltraSlim™ device at Baylor College of Medicine. No experimental interventions are introduced; patients are invited to participate after the clinical decision for POEM has been made. Investigators will collect procedural details, patient demographics, symptom measures, technical and clinical success, and adverse events from electronic medical records with follow-up at 30 days, 3 months, 6 months, and up to one year. The primary focus is to characterize technical feasibility, clinical outcomes, and the safety profile of POEM conducted with this device in routine practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (≥18 years of age)
* Diagnosed with achalasia or other esophageal motility disorders
* Scheduled to undergo clinically indicated per-oral endoscopic myotomy (POEM) using the Speedboat UltraSlim™ device
* Able and willing to provide informed consent

Exclusion Criteria:

* Patients under 18 years of age
* Patients not considered appropriate candidates for POEM by the principal investigator or treating physician

Where it's running

• Baylor College of Medicine
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Mohamed Othman, MD — Baylor College of Medicine
• Study coordinator: Mohamed Othman, MD
• Email: Mohamed.Othman@bcm.edu
• Phone: 7137980950

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults

  This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07780981

• Full-thickness vs progressive myotomy in POEM for achalasia

  This trial tests whether a full-thickness myotomy during POEM works better than a partial, progressive approach for people with achalasia, to see which method better relieves symptoms with fewer side effects.

  Recruiting at 2 sites Phase 2 Cairo University · Cairo and 1 other locations · NCT07875686

• POEM vs Heller myotomy with Dor fundoplication for achalasia

  This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.

  Recruiting Minia University · Minya, Minya Governorate · NCT07814027

• A registry for adults with esophageal movement and reflux problems.

  This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.

  Recruiting IRCCS San Raffaele · Milan, Lombardy · NCT07506746

• Using the SpydrBlade Flex device during POEM for achalasia and EGJ outflow obstruction

  This will test whether using the SpydrBlade Flex device during POEM is safe and effective for adults with achalasia or EGJ outflow obstruction.

  Recruiting at 2 sites Chinese University of Hong Kong · Guayaquil and 1 other locations · NCT07406945

• Indocyanine green fluorescence during laparoscopic Heller–Dor for achalasia

  This study will try using indocyanine green dye during laparoscopic Heller‑Dor in adults with type I or II achalasia to find mucosal leaks during surgery and help guide repairs.

  Recruiting Federico II University · Naples · NCT07181070

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.